ReviewOpen heart
Strengths and weaknesses of 'real-world' studies involving non-vitamin K antagonist oral anticoagulants.
A John Camm et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
77 papers cite itlatest 60 shown
pooled ittrialcites it